US drug can stop progress of COVID-19 - Israeli research
Orally available antiviral drug candidate Molnupiravir has the potential to prevent hospitalization if it is given to mild or moderate patients.
Colorful of tablets and capsules pill in blister packaging arranged with beautiful pattern with flare light. Pharmaceutical industry concept. Pharmacy drugstore. Antibiotic drug resistance
